These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 12684393

  • 41. Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.
    Berns EM, Klijn JG, Look MP, Grebenchtchikov N, Vossen R, Peters H, Geurts-Moespot A, Portengen H, van Staveren IL, Meijer-van Gelder ME, Bakker B, Sweep FC, Foekens JA.
    Clin Cancer Res; 2003 Apr; 9(4):1253-8. PubMed ID: 12684392
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.
    Anticancer Res; 2006 Apr; 26(6C):4985-90. PubMed ID: 17214375
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL.
    Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
    [Abstract] [Full Text] [Related]

  • 47. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
    Heck S, Rom J, Thewes V, Becker N, Blume B, Sinn HP, Deuschle U, Sohn C, Schneeweiss A, Lichter P.
    Cancer Res; 2009 Jun 15; 69(12):5186-93. PubMed ID: 19491275
    [Abstract] [Full Text] [Related]

  • 48. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.
    Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, Ohuchi N, Sasano H.
    Cancer Res; 2004 Jul 01; 64(13):4670-6. PubMed ID: 15231680
    [Abstract] [Full Text] [Related]

  • 49. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S, Kopp A, Grage B, Knabbe C.
    Anticancer Res; 2003 Jul 01; 23(1A):223-9. PubMed ID: 12680217
    [Abstract] [Full Text] [Related]

  • 50. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
    Ferrero-Poüs M, Hacène K, Bouchet C, Le Doussal V, Tubiana-Hulin M, Spyratos F.
    Clin Cancer Res; 2000 Dec 01; 6(12):4745-54. PubMed ID: 11156229
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
    Bièche I, Lazar V, Noguès C, Poynard T, Giovangrandi Y, Bellet D, Lidereau R, Vidaud M.
    Clin Cancer Res; 1998 Mar 01; 4(3):671-6. PubMed ID: 9533536
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirström K.
    J Clin Pathol; 2008 Feb 01; 61(2):197-203. PubMed ID: 18223096
    [Abstract] [Full Text] [Related]

  • 55. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients.
    Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL.
    Cancer Res; 1999 Nov 01; 59(21):5421-4. PubMed ID: 10554009
    [Abstract] [Full Text] [Related]

  • 56. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M.
    Cancer Res; 2002 Sep 01; 62(17):4849-53. PubMed ID: 12208729
    [Abstract] [Full Text] [Related]

  • 57. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q, Hu S, Gao H, Ma R, Yang Q, Pan Z, Wang T, Li F.
    Oncology; 2008 Sep 01; 75(3-4):159-68. PubMed ID: 18827493
    [Abstract] [Full Text] [Related]

  • 58. Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.
    Helleman J, Jansen MP, Ruigrok-Ritstier K, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Klijn JG, Sleijfer S, Foekens JA, Berns EM.
    Clin Cancer Res; 2008 Sep 01; 14(17):5555-64. PubMed ID: 18765548
    [Abstract] [Full Text] [Related]

  • 59. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T.
    J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.